Τίτλος:
Copanlisib, a PI3K Inhibitor, Demonstrates a Favorable Long-Term Safety
Profile in a Pooled Analysis of Patients with Hematologic Malignancies
Συγγραφείς:
Zinzani, Pier Luigi
Santoro, Armando
Mollica, Luigina
Leppa,
Sirpa
Follows, George A.
Lenz, Georg
Kim, Won Seog and
Nagler, Arnon
Panayiotidis, Panayiotis
Demeter, Judit and
Morschhauser, Franck
Munoz, Javier
Miriyala, Ashok
Benson,
Alice
Garcia-Vargas, Jose
Childs, Barrett H.
Dreyling,
Martin
